Skip to main content
. 2018 Jan 18;8:1161. doi: 10.1038/s41598-018-19516-6

Figure 1.

Figure 1

Therapeutic effect of Sham-MSCs and OVX-MSCs in OVX rats. (a) Experimental protocol for Sham and OVX rats treated with Vehicle, Sham-MSCs, or OVX-MSCs. (b) Representative micro-CT images of tibias. (cf) Quantitative changes in trabecular parameters, including trabecular bone volume, expressed as c: percentage of total tissue volume (BV/TV), d: trabecular thickness (Tb.Th), (e) Trabecular number (Tb.N), and (f) Trabecular separation (Tb.Sp). *P < 0.05. Data are expressed as mean ± SE of 4–5 animals. (g) Histological findings of the tibia in H&E-stained sections. Bar: 500 μm in upper panels, 100 μm in lower panels. (h) Immunofluorescence staining of the tibia with an anti-RANK antibody (red). DAPI was used for counterstaining nuclei (blue). Bar: 25 µm. (i) Immunofluorescence staining of the tibia with an anti-TRACP antibody (red). DAPI was used for counterstaining nuclei (blue). Bar: upper 50 μm, lower 25 µm. (j) Serum TRACP levels at the time of sacrifice of rats. *P < 0.05. Data are expressed as mean ± SE of 4–5 animals.